MCID: MCR011
MIFTS: 43

Microinvasive Gastric Cancer

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Microinvasive Gastric Cancer

MalaCards integrated aliases for Microinvasive Gastric Cancer:

Name: Microinvasive Gastric Cancer 12 15
Early Gastric Cancer 12 54 15 71
Surface Gastric Cancer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10541
NCIt 49 C27131
SNOMED-CT 67 276809004
UMLS 71 C0349530

Summaries for Microinvasive Gastric Cancer

MalaCards based summary : Microinvasive Gastric Cancer, also known as early gastric cancer, is related to helicobacter pylori infection and adenocarcinoma, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Microinvasive Gastric Cancer is TDRG1 (Testis Development Related 1), and among its related pathways/superpathways are Gastric acid production and Secretion of Hydrochloric Acid in Parietal Cells. The drugs Aspirin and Clarithromycin have been mentioned in the context of this disorder. Affiliated tissues include lymph node, liver and colon, and related phenotype is digestive/alimentary.

Related Diseases for Microinvasive Gastric Cancer

Diseases related to Microinvasive Gastric Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 417)
# Related Disease Score Top Affiliating Genes
1 helicobacter pylori infection 31.2 S100A8 MUC6 GAST
2 adenocarcinoma 31.2 VEGFC MLH1 CEACAM5 CDX2 CDH1
3 papillary adenocarcinoma 31.2 CEACAM5 CDX2 CDH1
4 tubular adenocarcinoma 31.2 MUC5AC CEACAM5 CDX2 CDH1
5 appendix adenocarcinoma 31.2 CEACAM5 CDX2
6 atrophic gastritis 31.0 S100A8 MUC6 GAST CDX2
7 gastrointestinal ulceration, recurrent, with dysfunctional platelets 31.0 S100A8 GAST
8 linitis plastica 31.0 CEACAM5 CDX2 CDH1
9 gastrointestinal carcinoma 30.9 GAST CEACAM5 CDX2
10 gastritis 30.9 S100A8 MUC6 GAST CDX2 CDH1 ATP4A
11 krukenberg carcinoma 30.9 CEACAM5 CDX2
12 postgastrectomy syndrome 30.9 GAST ATP12A
13 peptic esophagitis 30.8 S100A8 GAST CDX2 ATP4A ATP12A
14 adenoma 30.8 MUC6 MUC5AC MLH1 CDX2 CDH1
15 mucinous adenocarcinoma 30.7 MUC5AC MLH1 CEACAM5 CDX2
16 gastric adenocarcinoma 30.6 VEGFC S100A8 MLH1 GAST CEACAM5 CDX2
17 pernicious anemia 30.5 GAST ATP4A ATP12A
18 vitamin b12 deficiency 30.5 GAST ATP4A ATP12A
19 intrahepatic cholangiocarcinoma 30.4 MUC5AC CDX2 CDH1
20 neuroendocrine tumor 30.4 GAST CDX2 CDH1 ATP4A
21 gastric lymphoma 30.4 S100A8 ATP4A ATP12A
22 peptic ulcer disease 30.4 S100A8 MUC5AC GAST ATP4A ATP12A
23 lymphoma, mucosa-associated lymphoid type 30.3 S100A8 ATP4A ATP12A
24 hernia, hiatus 30.3 GAST ATP4A ATP12A
25 ascending colon cancer 30.3 MLH1 CEACAM5 CDX2
26 rectum adenocarcinoma 30.3 MLH1 CEACAM5 CDX2
27 marginal zone b-cell lymphoma 30.3 S100A8 ATP4A ATP12A
28 lymphocytic gastritis 30.1 ATP4A ATP12A
29 gastric tubular adenocarcinoma 30.1 MUC6 MUC5AC
30 gastroesophageal reflux 30.1 S100A8 GAST CDX2 ATP4A ATP12A
31 duodenogastric reflux 30.1 GAST ATP4A ATP12A
32 autoimmune gastritis 30.1 GAST ATP4A ATP12A
33 transverse colon cancer 30.0 SERPINB3 MLH1 CEACAM5
34 mediastinitis 30.0 ATP4A ATP12A
35 cholecystitis 30.0 S100A8 MUC6 MUC5AC CDH1
36 cholangiocarcinoma 30.0 VEGFC MUC5AC CEACAM5 CDX2 CDH1
37 bile reflux 29.9 S100A8 MUC5AC GAST CDX2 ATP4A ATP12A
38 signet ring cell adenocarcinoma 29.9 SERPINB3 PDPN MUC6 MUC5AC MLH1 CEACAM5
39 intestinal obstruction 29.9 CEACAM5 CDX2 ATP4A ATP12A
40 gastric cancer 29.8 XIST VEGFC TDRG1 S100A8 MUC6 MUC5AC
41 pseudomyxoma peritonei 29.6 MUC6 MUC5AC CEACAM5 CDX2 CDH1
42 villous adenoma 29.6 MUC6 MUC5AC MLH1 CEACAM5 CDX2
43 esophageal cancer 29.4 XIST VEGFC SERPINB3 MLH1 MIR196A1 CEACAM5
44 colorectal cancer 28.3 XIST VEGFC PDPN MUC6 MUC5AC MLH1
45 pancreatic cancer 28.1 XIST VEGFC MUC6 MUC5AC MLH1 MIR20A
46 ureter adenocarcinoma 10.6 CEACAM5 CDX2
47 laryngeal mucoepidermoid carcinoma 10.6 CEACAM5 CDX2
48 breast cystic hypersecretory carcinoma 10.6 CEACAM5 CDH1
49 pancreatic foamy gland adenocarcinoma 10.6 CEACAM5 CDX2
50 mucinous adenofibroma 10.6 CEACAM5 CDX2

Graphical network of the top 20 diseases related to Microinvasive Gastric Cancer:



Diseases related to Microinvasive Gastric Cancer

Symptoms & Phenotypes for Microinvasive Gastric Cancer

UMLS symptoms related to Microinvasive Gastric Cancer:


abdominal pain, dyspepsia

MGI Mouse Phenotypes related to Microinvasive Gastric Cancer:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.28 ATP12A ATP4A CDH1 CDX2 GAST GKN2

Drugs & Therapeutics for Microinvasive Gastric Cancer

Drugs for Microinvasive Gastric Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 113)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
2
Clarithromycin Approved Phase 4 81103-11-9 84029
3
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
4
Pantoprazole Approved Phase 4 102625-70-7 4679
5
Clopidogrel Approved Phase 4 113665-84-2, 120202-66-6 60606
6
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
7
Metronidazole Approved Phase 4 443-48-1 4173
8
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
9
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
10
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
11
Ecabet Investigational Phase 4 33159-27-2, 86408-72-2 65781
12 Analgesics, Non-Narcotic Phase 4
13 Fibrinolytic Agents Phase 4
14 Cyclooxygenase Inhibitors Phase 4
15 Platelet Aggregation Inhibitors Phase 4
16 Antipyretics Phase 4
17 Anti-Inflammatory Agents Phase 4
18 Antirheumatic Agents Phase 4
19 Anti-Inflammatory Agents, Non-Steroidal Phase 4
20 Purinergic P2Y Receptor Antagonists Phase 4
21 Cytochrome P-450 Enzyme Inhibitors Phase 4
22 Anti-Infective Agents Phase 4
23 Antiprotozoal Agents Phase 4
24 Anti-Bacterial Agents Phase 4
25 Antiparasitic Agents Phase 4
26 Cytochrome P-450 CYP3A Inhibitors Phase 4
27
protease inhibitors Phase 4
28 HIV Protease Inhibitors Phase 4
29 Protective Agents Phase 4
30 Antacids Phase 4
31 Proton Pump Inhibitors Phase 4
32 Anti-Ulcer Agents Phase 4
33 Gastrointestinal Agents Phase 4
34 Analgesics Phase 4
35 Anesthetics Phase 4
36 Hormones Phase 4
37 Anti-Arrhythmia Agents Phase 4
38 Anticonvulsants Phase 4
39 Calcium, Dietary Phase 4
40 calcium channel blockers Phase 4
41 Tocolytic Agents Phase 4
42
Calcium Nutraceutical Phase 4 7440-70-2 271
43
Meperidine Approved Phase 3 57-42-1 4058
44
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
45
Menthol Approved Phase 3 2216-51-5 16666
46
Epinephrine Approved, Vet_approved Phase 3 51-43-4 5816
47
Racepinephrine Approved Phase 3 329-65-7 838
48 Dermatologic Agents Phase 3
49 Hemostatics Phase 3
50 Pharmaceutical Solutions Phase 3

Interventional clinical trials:

(show top 50) (show all 117)
# Name Status NCT ID Phase Drugs
1 Effects of Ilaprazole 20mg on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone Endoscopic Submucosal Dissection(ESD) for Gastric Adenoma or Early Gastric Cancer. Unknown status NCT02638584 Phase 4 Ilaprazole;Rabeprazole
2 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
3 Efficacy of an Ecabet Sodium and Proton Pump Inhibitor (PPI) Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection: A Prospective Randomized Controlled Trial Unknown status NCT01308177 Phase 4 Ecabet
4 Helicobacter Pylori Eradication Rates of Concomitant Therapy and Tailored Therapy Based on 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance: A Multicenter Prospective Randomized Study Unknown status NCT03130452 Phase 4 Lansoprazole 30mg;Amoxicillin 1.0g Tab;Clarithromycin 500mg;Metronidazole 500 mg
5 The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study Completed NCT02235246 Phase 4 Magnesium Sulfate;Normal saline
6 Effects of Preoperative Administration of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection(EMR): Prospective, Randomized, Placebo-controlled, Comparative Study Completed NCT00844675 Phase 4 rabeprazole;placebo
7 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Unknown status NCT01157598 Phase 3
8 Morbidity and Mortality of Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients: A Randomized Controlled Trial Unknown status NCT02246153 Phase 3
9 Multicenter Study on Comparison of Long-term Outcome Between Laparoscopic and Open Distal Subtotal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer Unknown status NCT01609309 Phase 3
10 Effect of Helicobacter Pylori Eradication on the New Tumor Development After Endoscopic Resection of Gastric Tumors Completed NCT01510730 Phase 3 eradication treatment of Helicobacter pylori infection
11 Phase III Placebo-controlled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy (Randomized, Double-blind, Parallel-assignment, Placebo-controlled Study) Completed NCT01411176 Phase 3 Menthol;Placebo
12 Prospective Randomized Trial of Laparoscopy-assisted Distal Gastrectomy (LADG) Versus Open Distal Gastrectomy (ODG) in Patients With Early Gastric Cancer (EGC) Completed NCT00546468 Phase 3
13 Effect of Aspirin for the Gastric Cancer Prevention in Early Gastric Cancer Patients Who Underwent Endoscopic Resection: a Randomized Controlled Trial Recruiting NCT04214990 Phase 3 Aspirin 100mg;Placebo oral tablet
14 Multicenter Randomized Controlled Trial Comparing Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy for the Middle Third Early Gastric Cancer (KLASS-04) Recruiting NCT02595086 Phase 3
15 Prospective Multicenter Study on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery for Locally Advanced Gastric Cancer Recruiting NCT02748551 Phase 3
16 Multicenter Randomized Controlled Trial of Gastric Endoscopic Submucosal Dissection With or Without Epineprhine Added Solution Recruiting NCT04032119 Phase 3 Epinephrine
17 Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer Active, not recruiting NCT01804998 Phase 3
18 Phase III Study on Comparison for Bile Reflux and Gastric Stasis in Patients With Gastric Cancer After Distal Gastrectomy Withdrawn NCT00622804 Phase 3
19 A Phase II Study of Robot Assisted Distal Gastrectomy With Nodal Dissection for Clinical Stage Ia Gastric Cancer Unknown status NCT01504997 Phase 2
20 The Effect of Uncut Roux-en-Y Gastrojejunostomy on Quality of Life After Laparoscopic Distal Gastrectomy for Early Gastric Cancer Patients Unknown status NCT02644148 Phase 2
21 Prospective Multi-center Study of Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03) Unknown status NCT01584336 Phase 2
22 Laparoscopic Gastrectomy for Advanced Gastric Cancer Completed NCT01441336 Phase 2
23 Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer Completed NCT01441310 Phase 2
24 The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer Completed NCT02347956 Phase 1, Phase 2
25 A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic-assisted Gastrectomy in Early Gastric Cancer Patients Completed NCT02522598 Phase 2 VVZ-149 injections;Placebo
26 A Phase-II Clinical Trial of Laparoscopy-Assisted Distal Gastrectomy With D2 Lymph Node Dissection for Gastric Cancer Completed NCT01163812 Phase 2
27 Randomized Phase II Study of FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Patients With Advanced or Relapsed Gastric Cancer Completed NCT01138904 Phase 2 irinotecan, oxaliplatin;oxaliplatin, irinotecan
28 A Study to Assess Near Infrared Laparoscopy With Indocyanine Green (ICG) for Intraoperative Lymphatic Imaging and Sentinel Lymph Node Identification During Standard Surgical Resection for Colonic Cancer Completed NCT01662752 Phase 2 Indocyanine green
29 Non-exposure Simple Suturing Endoscopic Full-Thickness Resection (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) Recruiting NCT03837301 Phase 2
30 Preoperative S-1 Plus Cisplatin-based Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma : Randomized, Phase II Trial Recruiting NCT03814759 Phase 2 TS-1 + cisplatin
31 Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients: a Phase II Randomized Parallel Controlled Trial Recruiting NCT03564834 Phase 2
32 Prospective Study of Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion and Endoscopic Tumor Size Estimation for Early Gastric Cancer Unknown status NCT01832246
33 Pilot Study of Non-exposure Simple Suturing EFTR (NESS-EFTR) With Sentinel Lymph Node Navigation for Early Gastric Cancer (Senorita3-pilot) Unknown status NCT03216174
34 Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer Unknown status NCT01659632
35 Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection:a New Therapy for Early Gastric Cancer Unknown status NCT02325999 Early Phase 1
36 The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer and Evaluate the Invasive Depth of Tumors Unknown status NCT02710838
37 Long-term Follow-up After Endoscopic Submucosal Dissection for Early Gastric Cancer Unknown status NCT01132469
38 Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer: Multicenter Prospective Randomized Comparison Study Unknown status NCT01742806
39 Standardization of D2 Lymphadenectomy and Surgical Quality Control for KLASS-02 Trial: KLASS-02-QC Unknown status NCT01283893
40 Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection Unknown status NCT02090062
41 Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial Unknown status NCT01179724 high dose proton pump inhibitor;H2RB
42 Probe-based Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia,Intraepithelial Neoplasia,and Carcinoma:A Multicenter,Randomized,Controlled Trial Unknown status NCT02515721
43 An Educational Intervention, the First Step of the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer:Prospective Study With Historical Control Unknown status NCT02385578
44 The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia(GIM) Unknown status NCT01491724
45 Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy, Randomized Prospective Pilot Study Unknown status NCT02837874
46 Development and Validation of a Predictive Model for Early Gastric Cancerous Lesions Under Endoscopic Observation Unknown status NCT02968069
47 Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection Unknown status NCT02037399 intravenous dexamethasone;intravenous normal saline
48 Laparoscopic Reinforcement Suture (LARS) on Staple-line of Duodenal Stump Using Barbed Suture in Laparoscopic Gastrectomy for Gastric Cancer: A Prospective Single Arm Phase II Study Unknown status NCT03085199
49 The Effect and Mechanism of Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With DM Who Receive Surgical Treatment Unknown status NCT01375738
50 Serum Cholesterol and Gastric Neoplasm: Nested Case-control Study Unknown status NCT02041312

Search NIH Clinical Center for Microinvasive Gastric Cancer

Genetic Tests for Microinvasive Gastric Cancer

Anatomical Context for Microinvasive Gastric Cancer

MalaCards organs/tissues related to Microinvasive Gastric Cancer:

40
Lymph Node, Liver, Colon, Bone, Testes, Spleen, Bone Marrow

Publications for Microinvasive Gastric Cancer

Articles related to Microinvasive Gastric Cancer:

(show top 50) (show all 4650)
# Title Authors PMID Year
1
Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. 54 61
19117016 2009
2
Histopathological predictor for regional lymph node metastasis in gastric cancer. 61 54
19104832 2009
3
Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein. 61 54
18648315 2009
4
Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. 61 54
19940363 2009
5
[Effect of surgical manipulation on the dissemination of cancer cells into peripheral blood in patients with gastric cancer and its risk factor analysis]. 54 61
17520381 2007
6
[Expression of epithelial cadherin in early gastric cancer and its correlation to lymph node micrometastasis and clinicopathologic features]. 54 61
17672949 2007
7
[Clinicopathological and biological features of micrometastasis in early gastric cancers]. 61 54
17571311 2007
8
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. 61 54
17261130 2007
9
Detection of lymph node micrometastasis in pN0 early gastric cancer: efficacy of duplex RT-PCR with MUC2 and TFF1 in mucosal cancer. 54 61
16820924 2006
10
Histologic and serum risk markers for noncardia early gastric cancer. 54 61
15688378 2005
11
Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer. 61 54
15902740 2005
12
Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma. 61 54
15513361 2004
13
[Expression of beta-catenin and E-cadherin in early gastric cancer: correlation with clinicopathologic parameters]. 54 61
14978364 2004
14
[Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer]. 54 61
12776596 2003
15
Relationship between gastric disease and deletion of cag pathogenicity island genes of Helicobacter pylori in gastric juice. 61 54
12645789 2003
16
The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. 61 54
12552462 2003
17
Evaluation of carcinoembryonic antigen mRNA in living, necrotic, and apoptotic gastric cancer cells by reverse transcriptase-polymerase chain reaction. 54 61
14605956 2003
18
Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. 61 54
11856141 2002
19
BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer. 54 61
12378338 2002
20
BGP expression in gastric epithelium and early gastric cancer. 61 54
12378336 2002
21
[A case of radiologically negative small-cell lung carcinoma successfully detected early by whole-body FDG-PET]. 54 61
11296386 2001
22
Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. 61 54
11684825 2001
23
Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. 61 54
11706763 2001
24
Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. 54 61
11113859 2000
25
Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. 54 61
10642939 1999
26
Loss of E-cadherin expression in early gastric cancer. 54 61
10231415 1999
27
[The expression of thymidylate synthase and thymidine phosphorylase in the early-stage of gastric cancer]. 54 61
10065095 1999
28
Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. 61 54
10461060 1999
29
The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer. 54 61
9681606 1998
30
High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. 61 54
9175208 1997
31
Single-cell mutation analysis of tumors from stained histologic slides. 54 61
8973475 1996
32
Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas. 61 54
8641546 1996
33
Chitosan: A compound for drug delivery system in gastric cancer-a review. 61
32564837 2020
34
Cervical squamous cell carcinoma coexisting with ectopic gastric mucosa treated by endoscopic submucosal dissection: A case report. 61
32454971 2020
35
Evaluation of postoperative quality of life by PGSAS-45 following local gastrectomy based on the sentinel lymph node concept in early gastric cancer. 61
32086650 2020
36
Near-infrared fluorescent clip guided gastrectomy: Report of 2 cases (Case reports). 61
32461802 2020
37
Long term oncological outcome of patients with grossly early gastric cancer-mimicking advanced gastric cancer. 61
32234324 2020
38
Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction. 61
31432324 2020
39
Statins and metachronous recurrence after endoscopic resection of early gastric cancer: a nationwide Korean cohort study. 61
31980964 2020
40
Benefits of linked color imaging for recognition of early differentiated-type gastric cancer: in comparison with indigo carmine contrast method and blue laser imaging. 61
32556753 2020
41
[Does sentinel lymph node identification has indication in digestive cancers?] 61
31627907 2020
42
Impact of truncal vagotomy on complicated peptic ulcer after distal gastrectomy with reconstruction by jejunal pouch interposition. 61
32488527 2020
43
Optimal procedure-related hospitalization using clinical pathway protocols following gastric endoscopic submucosal dissection. 61
32556774 2020
44
Distal Gastrectomy with Billroth II Reconstruction is Associated with Oralization of Gut Microbiome and Intestinal Inflammation: A Proof-of-Concept Study. 61
32504369 2020
45
Efficacy of Endoscopic Submucosal Dissection for Superficial Gastric Neoplasia in a Large Cohort in North America. 61
32565290 2020
46
Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis. 61
32355093 2020
47
Polyglycolic acid sheets decrease post-endoscopic submucosal dissection bleeding in early gastric cancer: a systematic review and meta-analysis. 61
32573104 2020
48
Clinical significance of endoscopic ultrasonography in diagnosing invasion depth of early gastric cancer prior to endoscopic submucosal dissection. 61
32572791 2020
49
Integrating SWATH-MS Proteomics and Transcriptome Analysis Identifies CHI3L1 as a Plasma Biomarker for Early Gastric Cancer. 61
32346614 2020
50
Laparoscopy-assisted pylorus-preserving gastrectomy versus laparoscopy-assisted distal gastrectomy for early gastric cancer in perioperative outcomes: A meta-analysis. 61
32527581 2020

Variations for Microinvasive Gastric Cancer

Expression for Microinvasive Gastric Cancer

Search GEO for disease gene expression data for Microinvasive Gastric Cancer.

Pathways for Microinvasive Gastric Cancer

Pathways related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.8 MUC6 GAST
2 9.32 GAST ATP4A

GO Terms for Microinvasive Gastric Cancer

Cellular components related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.56 VEGFC SERPINB3 S100A8 MUC5AC MIR20A GKN2
2 extracellular region GO:0005576 9.28 VEGFC SERPINB3 S100A8 MUC6 MUC5AC GKN2

Biological processes related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular sodium ion homeostasis GO:0006883 9.32 ATP4A ATP12A
2 sodium ion export across plasma membrane GO:0036376 9.26 ATP4A ATP12A
3 cellular potassium ion homeostasis GO:0030007 9.16 ATP4A ATP12A
4 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 8.96 ATP4A ATP12A
5 autocrine signaling GO:0035425 8.62 SERPINB3 S100A8

Molecular functions related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP4A ATP12A
2 potassium-transporting ATPase activity GO:0008556 8.96 ATP4A ATP12A
3 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A

Sources for Microinvasive Gastric Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....